Effect of Terminalia chebula, Pistacia lentiscus and brown sugar oral combination in covid-19 treatment

Phase 3

Recruiting

• Conditions: U07.1; new Corona virus disease 2019.; new Corona virus disease 2019

• Registration Number: IRCT20210803052060N1
• Lead Sponsor: Artesh University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 November 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Men and women above 18 years with positive PCR test for Covid-19
At least two of these findings: GGO>10%, SO2<93%, RR>20, at least one underlying disease (COPD, HF, HTN, DM, Asthma, Immunodeficiency)
Conscious written consent to participate in the study

Exclusion Criteria

Covid vaccination history
Participation in another clinical trial

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ICU admision or intubation. Timepoint: During hospitalization, daily. Method of measurement: Evaluator report.

Secondary Outcome Measures

Name	Time	Method
Clinical symptoms(The degree of shortness of breath, cough intensity). Timepoint: During hospitalization, daily. Method of measurement: Symptoms by asking the patient as a scale indicator and signs by monitoring the patient by the assessor.;Inflammatory markers (ESR, CRP, LDH, WBC). Timepoint: before and after the 5 days intervention. Method of measurement: Quantitative laboratory measurements of blood samples.;Clinical examinations (RR, SO2). Timepoint: During hospitalization, daily. Method of measurement: Through clinical examination and use of pulse oximeter.